Lexicon Investigational Site — Hazelwood, Missouri

Lexicon Investigational Site is a clinical research site located in Hazelwood, Missouri, United States 63042.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Lexicon Investigational Site has participated in 3 clinical trials.

Therapeutic areas: Postherpetic Neuralgia, Diabetic Peripheral Neuropathy, Diabetes.

Sponsors: Lexicon Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hazelwood

Browse all research sites in Missouri · View every site in Hazelwood

• Healthcare Research Network
• Research Site
• Healthcare Research Network-Hazelwood
• Healthcare Research Network - St. Louis
• Healthcare Research Network - Hazelwood MO
• Aptinyx Clinical Site
• HealthCare Research
• Investigative Site
• Ferguson-Florissant School District
• Novo Nordisk Investigational Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lexicon Investigational Site?

Lexicon Investigational Site has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lexicon Investigational Site conducted?

Lexicon Investigational Site has 3 clinical trials on record. Their work covers Postherpetic Neuralgia, Diabetic Peripheral Neuropathy, Diabetes.

Is Lexicon Investigational Site accredited by Crixeo Clinical Trials?

Lexicon Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lexicon Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.